Etienne Sokal, M.D., Ph.D., CEO

April 21 | 2:15pm | Gaudi 2 Ballroom

Mont-Saint-Guibert, Belgium


In-Person Presentation

Cellaïon is a new company created in 2021, using cell signaling technology to treat life threatening liver diseases. The company is currently in phase IIB clinical development, actively recruiting, in Acute on Chronic Liver Failure.


By using this website you agree to accept our Privacy Policy and Terms & Conditions